Medicine & Health

School of Medicine physicians led efforts to create a repository for storing and managing specimens collected from patients with COVID-19. The samples are being distributed to investigators conducting COVID-19 research across the university.

Scientists at the Washington University School of Medicine have developed a mouse model of COVID-19 that is expected to speed up the search for drugs and vaccines for the potentially deadly disease.

Scientists at Washington University School of Medicine have developed a way to guide human stem cells into becoming important precursor cells that give rise to the placenta. These stem cells could help scientists understand miscarriage or preeclampsia.

Researchers at Washington University in St. Louis and the National Institutes of Health (NIH) have found that genes that confer the power to destroy tetracyclines are widespread in bacteria that live in the soil and on people.

Blood tests for antibodies against the COVID-19 virus are becoming more available, but no test is perfectly reliable, so results must be carefully interpreted, Washington University School of Medicine experts say.

Researchers at Washington University School of Medicine have received two grants from the National Institutes of Health (NIH) totaling more than $5 million to study two types of parasitic worm infection that cause devastating illness in millions of people worldwide.

Researchers at the School of Medicine are helming a global study of an estimated 30,000 health-care workers to establish whether the antimalaria drug chloroquine might prevent or reduce the severity of COVID-19 infections in such workers.

People with the genetic condition neurofibromatosis type 1 are prone to developing tumors on nervous system tissue. A new study from Washington University School of Medicine has found that the development and growth of such tumors are driven by nearby noncancerous neurons and immune cells.

A biomarker in newborns may signal autism spectrum disorder months or even years before troubling symptoms develop and such diagnoses typically are made. Researchers at Washington University School of Medicine and Stanford University found that some newborns had very low levels of a neuropeptide years before their diagnoses with autism spectrum disorder.

COVID-19 survivors are needed to donate blood plasma. Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program to give blood plasma from COVID-19 survivors to critically ill patients.